TAMPA, Fla. and LONDON, April 06, 2026 (GLOBE NEWSWIRE)-- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results